Subclinical hypothyroidism: A comparison of strategies to achieve adherence to treatment guidelines

Annals of Clinical Biochemistry

Volumn 41, Issue 3, 2004, Pages 197-200

  Lock, R J ^a   Marden, N A ^b   Kemp, H J ^a   Thomas, P H ^b   Goldie, D J ^a   Gompels, M M ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL PRACTICE; CONSENSUS; DATA ANALYSIS; FEMALE; HUMAN; HYPOTHYROIDISM; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH SERVICE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; STANDARD; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; UNITED KINGDOM;

ANTIBODIES; GUIDELINE ADHERENCE; HUMANS; HYPOTHYROIDISM; IODIDE PEROXIDASE; LABORATORIES, HOSPITAL; PRACTICE GUIDELINES; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE;

EID: 2442520436     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/000456304323019550     Document Type: Article

References (16)

1. Tunbddge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7: 481-93
2. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43: 55-68
3. Vanderpump MPJ, Ahlquist JOA, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. BMJ 1996; 313: 539-44
4. Chu JW, Crapo LM. The treatment of subclinical hypothyroidism is seldom necessary. J Clin Endocrinol Metab 2001; 86: 4591-9
5. Chu JW, Crapo LM. Should mild subclinical hypothyroidism be treated? Am J Med 2002; 112: 422-3
6. Fatourechi V. Mild thyroid failure (subclinical hypothyroidism): to treat or not to treat? Compr Ther 2002; 28: 134-9
7. Ayala AR, Wartofsky L. The case for more aggressive screening and treatment of mild thyroid failure. Cleve Clin J Med 2002; 69: 313-20
8. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med 1984; 101: 18-24
9. Nyström E, Caidahl K, Fager G, Wikkelsö C, Lundberg P-A, Lindstedt GA. A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol 1988; 29: 63-76
10. Jaeschke R, Guyatt G, Gerstein H, Patterson C, Molloy W, Cook D, et al. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med 1996; 11: 744-9
11. Anonymous. Managing subclinical hypothyroidism. Drug Ther Bull 1998; 36: 1-3
12. Woeber KA. Update on the management of hyperthyroidism and hypothyroidism. Arch Intern Med 2003; 160: 1067-71
13. Cooper DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med 2001; 345: 260-5
14. Jones RG, Payne RB. Medical Research: Study Design, Analysis and Reporting. Clinical Investigation and Statistics in Laboratory Medicine. London: ACB Venture publications, 1997: 124-84
15. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol 1991; 34: 73-83
16. Berry P. Audit of investigation of subclinical hypothyroidism in Scottish laboratories. Ann Clin Biochem 2002; 39: 26-33